QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ARDX

QT62Ardelyx, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
6.05
+0.21+3.60%
OverviewShort InterestFilings
ARDXQT62Ardelyx, Inc.·NASDAQ
OverviewShort InterestFilings
6.05+3.60%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-0.23
Insider Own7.71%
Shs Outstand247.03M
Perf Week4.49%
Market Cap1.44BForward P/E12.43EPS next Y0.49Insider Trans0.06%Shs Float-Perf Month-0.66%
Enterprise Value1.62BPEG2.33EPS next Q-0.03Inst Own-Short Float-Perf Quarter10.00%
Income-58283034.00P/S3.37EPS this Y76.88%Inst Trans-Short Ratio-Perf Half Y0.83%
Sales427.68MP/B9.66EPS next Y1015.79%ROA-11.51%Short Interest-Perf YTD3.77%
Book/sh0.60P/C-EPS next 5Y-ROE-38.11%52W High8.40 -27.98%Perf Year70.42%
Cash/sh0.96P/FCF-EPS past 3/5Y-ROIC-9.44%52W Low3.49 73.35%Perf 3Y-
Dividend Est.-EV/EBITDA-63.47Sales past 3/5Y98.55% 119.43%Gross Margin91.93%Volatility3.02% 3.02%Perf 5Y-
Dividend TTM-EV/Sales3.79EPS Y/Y TTM-25.89%Oper. Margin-8.75%ATR (14)0.28Perf 10Y-
Dividend Ex-Date-Quick Ratio3.28Sales Y/Y TTM19.16%Profit Margin-13.58%RSI (14)54.57Recom2.00
Dividend Gr. 3/5Y-Current Ratio3.49EPS Q/Q11.76%SMA204.06%Beta0.91Target Price17.00
Payout0.00%Debt/Eq1.40Sales Q/Q27.03%SMA50-1.69%Rel Volume2.65Prev Close5.84
Employees395LT Debt/Eq1.26EarningsAug 03SMA200-1.10%Avg Volume3.70MPrice6.05
IPO DateJun 19, 2014Option/ShortYes / YesEPS/Sales Surpr.-15.38% 1.08%Net Debt/EBITDA-6.94Volume9,835,132Change3.60%
Analyst Ratings
DateActionAnalystRatingTarget
Mar-12-26ReiteratedWilliams Trading$17
Feb-20-26ReiteratedH.C. Wainwright$10 → $18
Jan-27-26ReiteratedJefferiesBuy$8.00 → $15
Jan-09-26UpgradePiper SandlerNeutral → Overweight$16
Jan-09-26ReiteratedBTIGBuy$14 → $17
Jan-08-26ReiteratedRaymond JamesOutperform$16 → $19
Nov-04-25ReiteratedPiper SandlerNeutral$10
Aug-05-25ReiteratedUBS$11 → $12
Aug-05-25ReiteratedWedbushOutperform$2.00 → $14
Mar-04-25InitiatedBTIGBuy$14
Latest News
Jun-16-26
Jun-16-2612:53PM
Ladenburg Thalmann Assumes Ardelyx at Buy, Announces Price Target of $16Benzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue398407334
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A494351
Gross Profit349365283
Selling, General and Administrative Excl. Other327337259
Research and Development606852
Other Operating Expense110
Operating Income-37-41-28
Interest Expense272820
Unusual Expense
———
Non-Operating Income (Expense)-8-9-9
Net Income Before Taxes-55-61-39
Income Taxes110
Consolidated Net Income-56-62-39
Net Income From Continuing Operations-56-62-39
Net Income-56-62-39
EPS (Recurring)-0.23-0.26-0.17
EPS (Basic, Before Extraordinaries)-0.23-0.26-0.17
EPS (Diluted)-0.23-0.26-0.17
EBITDA-26-29-17
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio3.683.45—
Gross Margin87.6989.6884.73
Operating Margin-9.30-10.07-8.38
Net Margin-14.07-15.23-11.68
Shares Outstanding242241235
Market Capitalization1,4641,405—
Operating Lease Expense
———
Insider Trading Volume
$6.44$5.77$5.11$4.45$3.78● Close Price0.00M0.49M0.97M1.46M1.95MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
RAAB MICHAELPresident & CEOJun 15 '26Option Exercise0.9941,66641,2501,740,866Jun 17 12:00 AM
RAAB MICHAELPresident & CEOJun 15 '26Sale5.6741,666236,3461,699,200Jun 17 12:00 AM
Reilly Joseph JamesSee RemarksMay 21 '26Sale6.273,71923,309149,107May 22 12:00 AM
Hohenleitner SusanChief Financial OfficerMay 21 '26Sale6.271,4559,119229,078May 22 12:00 AM
Bishop John ESee RemarksMay 21 '26Sale6.272,30614,453336,845May 22 12:00 AM
Brady James ParkerChief Human Resources OfficerMay 21 '26Sale6.271,84611,570261,066May 22 12:00 AM
Foster Eric DuaneChief Commercial OfficerMay 21 '26Sale6.277,99850,127417,972May 22 12:00 AM
Kelliher MikeChief Business OfficerMay 21 '26Sale6.277,24845,427357,418May 22 12:00 AM
Williams Laura AChief Patient OfficerMay 21 '26Sale6.276,98943,803429,093May 22 12:00 AM
RAAB MICHAELPresident & CEOMay 21 '26Sale6.2754,748343,1331,720,033May 22 12:00 AM
RAAB MICHAELPresident & CEOMay 15 '26Option Exercise0.9941,66641,2501,816,447May 19 12:00 AM
RAAB MICHAELPresident & CEOMay 15 '26Sale6.2841,666261,6121,774,781May 19 12:00 AM
RAAB MICHAELPresident & CEOApr 15 '26Option Exercise0.9941,66841,2521,837,282Apr 17 12:00 AM
RAAB MICHAELPresident & CEOApr 15 '26Sale6.2941,668261,9541,795,614Apr 17 12:00 AM
RAAB MICHAELPresident & CEOMar 16 '26Option Exercise0.9941,66641,2501,856,986Mar 18 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR